Skip to main content
. 2018 Oct 17;20(3):321–327. doi: 10.1080/15384047.2018.1529099

Figure 3.

Figure 3.

Efficacy of the combination of TACE and apatinib.

(A) Kaplan–Meier survival curve showing the probability of overall survival (OS) stratifed by BCLC B and BCLC C. (B) Probability of progression-free survival (PFS) stratifed by BCLC B and BCLC C. The result showed patients with BCLC B has longer PFS and OS than BCLC C.